Research-driven journalism across multiple industries.
Displaying items 41981-41982 of 41982 in total
Nutriband Inc. receives positive FDA feedback on its AVERSA™ FENTANYL patch, a novel approach to combating opioid misuse. The company is poised to enter clinical trials with a potential peak US market of $80-$200 million.
Tom Golisano commits $253 million to expand pediatric care access through a new hospital alliance, bringing his lifetime charitable giving over $1 billion. Is this collaborative model the future of children’s health?